Lenin Pavón

Prof. Lenin Pavón

Psychoimmunology, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2007 in Bipolar Disorders
Verified
Journal Article
Closed access
PDF file
AOAbigail Ortiz‐Domínguez
Abigail Ortiz‐Domínguez
MHMaría Eugenia Hernández
María Eugenia Hernández
CBCarlos Berlanga
Carlos Berlanga
DGDoris Gutiérrez‐Mora
Doris Gutiérrez‐Mora
JMJulia Moreno
Julia Moreno
Lenin PavónLenin Pavón
Lenin Pavón

2 January 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SSSamantha R. Slight
Samantha R. Slight
RJRangel Moreno Javier
Rangel Moreno Javier
RGRadha Gopal
Radha Gopal
YLYinyao Lin
Yinyao Lin
BJBeth A. Fallert Junecko
Beth A. Fallert Junecko
SKShabaana A. Khader
Shabaana A. Khader
One third of the world’s population is infected with Mycobacterium tuberculosis (Mtb). Although most infected people remain asymptomatic, they have a 10% lifetime risk of developing active tuberculosis (TB). Thus, the current challenge is to identify immune parameters that distinguish individuals with latent TB from those with active TB. Using human and experimental models of Mtb infection, we demonstrated that organized ectopic lymphoid structures containing CXCR5+ T cells were present in Mtb-infected lungs. In addition, we found that in experimental Mtb infection models, the presence of CXCR5+ T cells within ectopic lymphoid structures was associated with immune control. Furthermore, in a mouse model of Mtb infection, we showed that activated CD4+CXCR5+ T cells accumulated in Mtb-infected lungs and produced proinflammatory cytokines. Mice deficient in Cxcr5 had increased susceptibility to TB due to defective T cell localization within the lung parenchyma. We demonstrated that CXCR5 expression in T cells mediated correct T cell localization within TB granulomas, promoted efficient macrophage activation, protected against Mtb infection, and facilitated lymphoid follicle formation. These data demonstrate that CD4+CXCR5+ T cells play a protective role in the immune response against TB and highlight their potential use for future TB vaccine design and therapy.

1 January 2015 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
EIElizabeth G. Ibarra-Coronado
Elizabeth G. Ibarra-Coronado
APAna Ma. Pantaleón-Martínez
Ana Ma. Pantaleón-Martínez
JVJavier Velazquéz-Moctezuma
Javier Velazquéz-Moctezuma
OPOscar Prospéro-García
Oscar Prospéro-García
MMMónica Méndez-Díaz
Mónica Méndez-Díaz
Jorge Morales-MontorJorge Morales-Montor
Jorge Morales-Montor
Sleep is considered an important modulator of the immune response. Thus, a lack of sleep can weaken immunity, increasing organism susceptibility to infection. For instance, shorter sleep durations are associated with a rise in suffering from the common cold. The function of sleep in altering immune responses must be determined to understand how sleep deprivation increases the susceptibility to viral, bacterial, and parasitic infections. There are several explanations for greater susceptibility to infections after reduced sleep, such as impaired mitogenic proliferation of lymphocytes, decreased HLA-DR expression, the upregulation of CD14+, and variations in CD4+ and CD8+ T lymphocytes, which have been observed during partial sleep deprivation. Also, steroid hormones, in addition to regulating sexual behavior, influence sleep. Thus, we hypothesize that sleep and the immune-endocrine system have a bidirectional relationship in governing various physiological processes, including immunity to infections. This review discusses the evidence on the bidirectional effects of the immune response against viral, bacterial, and parasitic infections on sleep patterns and how the lack of sleep affects the immune response against such agents. Because sleep is essential in the maintenance of homeostasis, these situations must be adapted to elicit changes in sleep patterns and other physiological parameters during the immune response to infections to which the organism is continuously exposed.

1 January 2015 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
RARodrigo Arreola
Rodrigo Arreola
Enrique Becerril VillanuevaEnrique Becerril Villanueva
Enrique Becerril Villanueva
CCCarlos Cruz-Fuentes
Carlos Cruz-Fuentes
Marco Velasco-VelazquezMarco Velasco-Velazquez
Marco Velasco-Velazquez
MGMaría Eugenia Garcés-Alvarez
María Eugenia Garcés-Alvarez
Lenin PavónLenin Pavón
Lenin Pavón
Serotonin (5-HT) induces concentration-dependent metabolic effects in diverse cell types, including neurons, entherochromaffin cells, adipocytes, pancreatic beta-cells, fibroblasts, smooth muscle cells, epithelial cells, and leukocytes. Three classes of genes regulating 5-HT function are constitutively expressed or induced in these cells: (a) membrane proteins that regulate the response to 5-HT, such as SERT, 5HTR-GPCR, and the 5HT3-ion channels; (b) downstream signaling transduction proteins; and (c) enzymes controlling 5-HT metabolism, such as IDO and MAO, which can generate biologically active catabolites, including melatonin, kynurenines, and kynurenamines. This review covers the clinical and experimental mechanisms involved in 5-HT-induced immunomodulation. These mechanisms are cell-specific and depend on the expression of serotonergic components in immune cells. Consequently, 5-HT can modulate several immunological events, such as chemotaxis, leukocyte activation, proliferation, cytokine secretion, anergy, and apoptosis. The effects of 5-HT on immune cells may be relevant in the clinical outcome of pathologies with an inflammatory component. Major depression, fibromyalgia, Alzheimer disease, psoriasis, arthritis, allergies, and asthma are all associated with changes in the serotonergic system associated with leukocytes. Thus, pharmacological regulation of the serotonergic system may modulate immune function and provide therapeutic alternatives for these diseases.

1 January 2016 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
DMDanelia Mendieta
Danelia Mendieta
DCDora Luz De la Cruz-Aguilera
Dora Luz De la Cruz-Aguilera
MBMaria Isabel Barrera-Villalpando
Maria Isabel Barrera-Villalpando
Enrique Becerril VillanuevaEnrique Becerril Villanueva
Enrique Becerril Villanueva
RARodrigo Arreola
Rodrigo Arreola
Lenin PavónLenin Pavón
Lenin Pavón

1 March 2006 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
Lenin PavónLenin Pavón
Lenin Pavón
GSGabriel Sandoval-López
Gabriel Sandoval-López
MHMaría Eugenia Hernández
María Eugenia Hernández
FLFrida Loria
Frida Loria
IEIris Estrada
Iris Estrada
GHGerhard Heinze
Gerhard Heinze